Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuya Minami

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 7, 2015
Comparison of improved prognosis between hepatitis B- and hepatitis C-related hepatocellular carcinomaTatsuya Minami, Ryosuke Tateishi, Shuichiro Shiina, et al.
Case Reports in Gastroenterology|January 24, 2013
IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF SignalKazuya Okushin, Yoshinari Asaoka, Izumi Fukuda, et al.
Liver Cancer|June 26, 2025
The Risk of Decompensation in Steatotic Liver Disease-Related Hepatocellular Carcinoma: A Comparison with Viral-Controlled CasesYuki Matsushita, Tatsuya Minami, Yoshikuni Kawaguchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 21, 2018
Ischemic complications after percutaneous radiofrequency ablation of liver tumors: Liver volume loss and recoveryTaijiro Wake, Ryosuke Tateishi, Ryo Nakagomi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 23, 2026
Machine Learning Approach Enables Highly Accurate Identification of At-Risk Metabolic Dysfunction-Associated SteatohepatitisMasaya Sato, Takuma Nakatsuka, Tatsuya Minami, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 24, 2023
Clinical utility of postablation liver tumor biopsy and possibility of gene mutation analysisTakuma Nakatsuka, Hayato Nakagawa, Koji Uchino, et al.
Plos One|April 21, 2020
Improved liver function in patients with cirrhosis due to chronic hepatitis C virus who achieve sustained virologic response is not accompanied by increased liver volumeTaijiro Wake, Ryosuke Tateishi, Tsuyoshi Fukumoto, et al.
Hepatology Communications|May 31, 2022
Improved prognosis of hepatitis C-related hepatocellular carcinoma in the era of direct-acting antiviralsTsuyoshi Fukumoto, Tatsuya Minami, Makoto Moriyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 28, 2014
Tumor markers are more useful in patients undergoing surveillance for hepatocellular carcinoma with unreliable results by ultrasonographyShintaro Mikami, Ryosuke Tateishi, Shu Hagiwara, et al.
Journal of Gastroenterology|March 13, 2021
Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinomaTakuma Nakatsuka, Hayato Nakagawa, Yuki Hayata, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 7, 2015
Comparison of improved prognosis between hepatitis B- and hepatitis C-related hepatocellular carcinomaTatsuya Minami, Ryosuke Tateishi, Shuichiro Shiina, et al.
Case Reports in Gastroenterology|January 24, 2013
IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF SignalKazuya Okushin, Yoshinari Asaoka, Izumi Fukuda, et al.
Liver Cancer|June 26, 2025
The Risk of Decompensation in Steatotic Liver Disease-Related Hepatocellular Carcinoma: A Comparison with Viral-Controlled CasesYuki Matsushita, Tatsuya Minami, Yoshikuni Kawaguchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 21, 2018
Ischemic complications after percutaneous radiofrequency ablation of liver tumors: Liver volume loss and recoveryTaijiro Wake, Ryosuke Tateishi, Ryo Nakagomi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 23, 2026
Machine Learning Approach Enables Highly Accurate Identification of At-Risk Metabolic Dysfunction-Associated SteatohepatitisMasaya Sato, Takuma Nakatsuka, Tatsuya Minami, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 24, 2023
Clinical utility of postablation liver tumor biopsy and possibility of gene mutation analysisTakuma Nakatsuka, Hayato Nakagawa, Koji Uchino, et al.
Plos One|April 21, 2020
Improved liver function in patients with cirrhosis due to chronic hepatitis C virus who achieve sustained virologic response is not accompanied by increased liver volumeTaijiro Wake, Ryosuke Tateishi, Tsuyoshi Fukumoto, et al.
Hepatology Communications|May 31, 2022
Improved prognosis of hepatitis C-related hepatocellular carcinoma in the era of direct-acting antiviralsTsuyoshi Fukumoto, Tatsuya Minami, Makoto Moriyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 28, 2014
Tumor markers are more useful in patients undergoing surveillance for hepatocellular carcinoma with unreliable results by ultrasonographyShintaro Mikami, Ryosuke Tateishi, Shu Hagiwara, et al.
Journal of Gastroenterology|March 13, 2021
Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinomaTakuma Nakatsuka, Hayato Nakagawa, Yuki Hayata, et al.
Pageof 7